Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Signet Ring Cell | 2 | 2020 | 83 | 1.350 |
Why?
|
| Stomach Neoplasms | 6 | 2022 | 1422 | 1.350 |
Why?
|
| Retroperitoneal Neoplasms | 2 | 2022 | 329 | 1.190 |
Why?
|
| Neoadjuvant Therapy | 8 | 2022 | 2821 | 1.090 |
Why?
|
| Rectal Neoplasms | 5 | 2022 | 1152 | 0.820 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2022 | 1152 | 0.810 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2021 | 15 | 0.790 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2021 | 2292 | 0.770 |
Why?
|
| Retroperitoneal Space | 1 | 2021 | 171 | 0.730 |
Why?
|
| Ligation | 1 | 2021 | 448 | 0.720 |
Why?
|
| Societies, Scientific | 1 | 2021 | 220 | 0.710 |
Why?
|
| Liver Transplantation | 2 | 2021 | 2325 | 0.650 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 286 | 0.620 |
Why?
|
| Liver Neoplasms | 4 | 2021 | 4313 | 0.610 |
Why?
|
| Peritoneal Neoplasms | 3 | 2020 | 707 | 0.590 |
Why?
|
| Gastrectomy | 2 | 2021 | 670 | 0.570 |
Why?
|
| Pelvis | 1 | 2021 | 743 | 0.550 |
Why?
|
| Rectum | 1 | 2021 | 895 | 0.550 |
Why?
|
| Sarcoma | 3 | 2022 | 1785 | 0.540 |
Why?
|
| Cholangiocarcinoma | 1 | 2019 | 550 | 0.450 |
Why?
|
| Perioperative Care | 1 | 2021 | 1028 | 0.440 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 1031 | 0.430 |
Why?
|
| Lymph Nodes | 2 | 2021 | 3485 | 0.420 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8530 | 0.400 |
Why?
|
| Adenocarcinoma | 4 | 2022 | 6313 | 0.390 |
Why?
|
| Hepatitis C | 1 | 2020 | 1579 | 0.350 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3056 | 0.320 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 9273 | 0.320 |
Why?
|
| Quality of Health Care | 1 | 2021 | 4317 | 0.260 |
Why?
|
| Retrospective Studies | 18 | 2022 | 80168 | 0.240 |
Why?
|
| Anastomotic Leak | 2 | 2021 | 163 | 0.210 |
Why?
|
| Neoplasm Staging | 7 | 2022 | 11152 | 0.210 |
Why?
|
| Appendiceal Neoplasms | 2 | 2020 | 155 | 0.190 |
Why?
|
| Survival Rate | 8 | 2021 | 12721 | 0.190 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 39059 | 0.180 |
Why?
|
| Fluorenes | 1 | 2021 | 157 | 0.180 |
Why?
|
| Carbamates | 1 | 2021 | 191 | 0.170 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2020 | 66 | 0.170 |
Why?
|
| Pyrrolidines | 1 | 2021 | 337 | 0.170 |
Why?
|
| Quinoxalines | 1 | 2021 | 297 | 0.170 |
Why?
|
| Thoracic Neoplasms | 1 | 2021 | 266 | 0.160 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2020 | 125 | 0.160 |
Why?
|
| Patient Selection | 2 | 2021 | 4244 | 0.160 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2020 | 184 | 0.160 |
Why?
|
| Biology | 1 | 2020 | 289 | 0.150 |
Why?
|
| Middle Aged | 17 | 2022 | 219568 | 0.150 |
Why?
|
| Preoperative Care | 3 | 2021 | 2249 | 0.150 |
Why?
|
| Hepatectomy | 1 | 2020 | 559 | 0.140 |
Why?
|
| Guided Tissue Regeneration | 1 | 2017 | 88 | 0.140 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 416 | 0.140 |
Why?
|
| Prognosis | 6 | 2021 | 29557 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2021 | 855 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2021 | 2020 | 0.130 |
Why?
|
| Humans | 27 | 2022 | 758406 | 0.120 |
Why?
|
| Male | 19 | 2022 | 358747 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2020 | 3527 | 0.120 |
Why?
|
| Female | 20 | 2022 | 390323 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 931 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2021 | 6821 | 0.110 |
Why?
|
| Aged | 12 | 2021 | 168218 | 0.110 |
Why?
|
| Magnesium | 1 | 2017 | 809 | 0.110 |
Why?
|
| Sciatic Nerve | 1 | 2017 | 613 | 0.110 |
Why?
|
| United States | 8 | 2021 | 72136 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 4839 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 5349 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 2414 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2021 | 1973 | 0.100 |
Why?
|
| Nerve Regeneration | 1 | 2017 | 790 | 0.100 |
Why?
|
| Postoperative Complications | 4 | 2020 | 15637 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2022 | 2147 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1648 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1930 | 0.090 |
Why?
|
| Adenoma | 1 | 2020 | 2148 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 1688 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1724 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 2882 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7818 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2021 | 7980 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7338 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3364 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10416 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11709 | 0.050 |
Why?
|
| Melanoma | 1 | 2021 | 5691 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 5797 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6852 | 0.050 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2020 | 92 | 0.040 |
Why?
|
| Calgranulin B | 1 | 2020 | 86 | 0.040 |
Why?
|
| Ileostomy | 1 | 2020 | 120 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 522 | 0.040 |
Why?
|
| Scalp | 1 | 2021 | 389 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20500 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2020 | 983 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13245 | 0.030 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2020 | 508 | 0.030 |
Why?
|
| Cell Count | 1 | 2020 | 1835 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2017 | 1154 | 0.030 |
Why?
|
| Polyesters | 1 | 2017 | 371 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2020 | 820 | 0.030 |
Why?
|
| Drainage | 1 | 2020 | 1161 | 0.030 |
Why?
|
| Registries | 2 | 2020 | 8175 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2021 | 6234 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3617 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6493 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 5490 | 0.020 |
Why?
|
| Axons | 1 | 2017 | 1673 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10112 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3887 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 1911 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10504 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 18358 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2020 | 18940 | 0.010 |
Why?
|
| Risk Factors | 2 | 2021 | 73809 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 39872 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 58683 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 64378 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 58808 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 87892 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 219935 | 0.000 |
Why?
|
| Animals | 1 | 2017 | 167768 | 0.000 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_